Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable Collagen Scaffold and MSCs for Brain Injury
NCT02767817Phase 1Unknown
- Sponsor
- Chinese Academy of Sciences
- Start
- Mar 2016
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mesenchymal stem cells in intracerebral hemorrhage (ICH), sponsored by Chinese Academy of Sciences. Primary endpoint: Number of adverse events and participants with those adverse events at 24 months. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02767817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767817.